Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRichard Fatica
About this trial
This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.
Eligibility criteria
Qualifiers
Adult (18 years or older)
Diagnosis of ADPKD by a physician.
Estimated glomerular filtration rate (eGFR) ≥ 30 mL/min/1.73 m2 at screening using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation.
Appropriate control of blood pressure (i.e. entry reading <140/90) including the use of BP medications for diagnosis of hypertension.
Disqualifiers
Intolerance or allergy to any of the ingredients in the provided medical food
History of hyperkalemia
Heart failure
Liver cirrhosis
Trial design
Treatments tested in this trial
- Ren-Nu and KetoCitra
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Richard Fatica
Lead sponsor
The Cleveland Clinic
Sponsor institution
Santa Barbara Nutrients
Collaborator
Source ClinicalTrials.gov